Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· Dr. Harshi Peiris | NeuroScope

Rapamycin vs Placebo, Both With Home Exercise, in Adults 65–85

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

At a glance

Automatic summary · not editorially reviewed

A description of a video about the RAPA-EX-01 trial: adults aged 65 to 85 all did the same home workout, half took weekly sirolimus and half placebo, and the placebo group gained more strength. The description says blocking mTOR may blunt muscle building during training. [1]

  1. The description says adults aged 65 to 85 all did the same home workout, with half taking weekly sirolimus and half placebo. [1]

  2. The description calls RAPA-EX-01 a randomized, double-blind, placebo-controlled trial. [1]

  3. According to the description, the placebo group gained more strength, and blocking mTOR may blunt muscle building during training. [1]

RAPA-EX-01: sirolimus or placebo alongside home exercise

The description presents RAPA-EX-01 as a randomized, double-blind, placebo-controlled trial in adults aged 65 to 85. Everyone did the same home workout. Half received weekly sirolimus (rapamycin), the other half a placebo. So the comparison is sirolimus versus placebo, with exercise in both groups, not drug versus exercise. The description names Stanfield et al., Journal of Cachexia, Sarcopenia and Muscle 2026, as the source. [1]

Placebo group gained more strength; mTOR link proposed

According to the description, the result surprised longevity fans: the placebo group gained more strength. The video is said to explain why blocking mTOR may blunt muscle building during training. This is presented as a possible explanation, not as a proven cause. The description does not report how much strength each group gained, how strength was measured, or how long the trial lasted. [1]

Side effects mentioned but not specified in the description

The description says viewers will learn what side effects appeared, but it does not name any. It also frames the content as education about healthy aging, muscle strength after 65 and exercise for seniors, and states it is not medical advice. No numbers on participants, side-effect rates or strength changes are given. [1]

Context & limits

This is only the video description. The video and transcript were not reviewed. Design details, participant numbers, follow-up, how strength was measured, effect sizes and side effects are not reported here. The mTOR explanation is presented as a possibility, not a proven cause.

Based on the creator’s description; the full video and transcript were not analyzed.

[1] Rapamycin vs Exercise: Placebo Made Seniors Stronger
Quoted passages in the original language
Everyone did the same home workout
Randomised, Double-Blind, Placebo-Controlled Trial
the placebo group gained more strength

About this video

Creator description · original language

A new randomized trial tested rapamycin in adults aged 65 to 85. Everyone did the same home workout. Half took weekly sirolimus, and half took placebo. The result surprised longevity fans. In this Short, Dr. Harshi Peiris breaks down the RAPA-EX-01 trial and what it means for healthy aging, muscle strength after 65, and exercise for seniors. You will learn why the placebo group gained more strength, what side effects appeared, and why blocking mTOR may blunt muscle building during training. This is educational and not medical advice. Talk to your doctor before changing exercise or medication. Study: Stanfield et al. Exercise and Weekly Sirolimus (Rapamycin) in Older Adults: RAPA-EX-01 Randomised, Double-Blind, Placebo-Controlled Trial. Journal of Cachexia, Sarcopenia and Muscle 2026, 17(2), e70274. Full text via PubMed: https://pubmed.ncbi.nlm.nih.gov/41985884/ Subscribe to NeuroScope for clear science on aging, brain health and clinical trials. #longevity #healthyaging #seniors #healthy #rapamycin

Dr. Harshi Peiris | NeuroScope · 2 min · Source published: 2026-10-19

Added to Harbor: 10/22/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…